Factors Associated to Success of Hepatitis C Therapy
- Conditions
- Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
- Interventions
- Registration Number
- NCT00514111
- Lead Sponsor
- UPECLIN HC FM Botucatu Unesp
- Brief Summary
The aim of this study is to evaluate the sustained virologic response (RVS) in HVC patients treated with pegylated-interferon or conventional-interferon and ribavirin, and to investigate the associated factors with RVS, by means of retrospective analysis.
- Detailed Description
Chronic hepatitis C virus(HVC) is a major public-health problem since it presents a long phase of clinical latency which makes its early diagnosis difficult and results in the development of a large number of cases to complications such as cirrhosis, hepatic insufficiency and hepatocarcinoma. In Brazil, it is estimated three million estimated cases to 52 thousand reports. The aim of this study is to evaluate the sustained virologic response (RVS) in HVC patients treated with pegylated-interferon or conventional-interferon and ribavirin, and to investigate the associated factors with RVS, by means of retrospective analysis.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- HVC patients that received specific treatment with pegylated-interferon or conventional-interferon, and ribavirin
- No HVC infection or treatment
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description HVC Patients pegylated-interferon, conventional-interferon, ribavirin HVC patients attended in SAE e HD.
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
SAE e Hospital Dia de Aids
🇧🇷Botucatu, Sao Paulo, Brazil